{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:44:48Z","timestamp":1760298288560},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[1991,10]]},"DOI":"10.1007\/bf03189971","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T03:31:33Z","timestamp":1281065493000},"page":"269-273","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose"],"prefix":"10.1007","volume":"16","author":[{"given":"J.","family":"Ramis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Forn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Torrent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gorina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Jan\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03189971_CR1","first-page":"337","volume":"32","author":"J. Garcia Rafanell","year":"1977","unstructured":"Garcia Rafanell J., Morell J. (1977): L\u2019effect inhibiteur de l\u2019acide 2-acetoxy-4-trifluoromethyl benzoique (triflusal) et de l\u2019aspirine sur l\u2019agregation des plaquettes chez l\u2019home et le rat Etude \u201cin vivo\u201d. Therapie, 32, 337\u2013344.","journal-title":"Therapie"},{"key":"BF03189971_CR2","first-page":"135","volume":"7","author":"M.J. Sancho","year":"1985","unstructured":"Sancho M.J., Castellamau C., Vila L., et al. (1985): Effects of salicylate derivatives on cyclooxygenase. Interaction studies. Biol. Clin. Hematol., 7, 135\u2013143.","journal-title":"Biol. Clin. Hematol."},{"key":"BF03189971_CR3","first-page":"13","volume":"9","author":"L. Gomez","year":"1987","unstructured":"Gomez L., Garcia Rafanell J., Fom J. (1987): Protective effect of triflusal and acetylsalicylic acid against arachidonic acid induced cerebrovascular occlusion in anaesthetized rats. Meth. Find. Exptl. Clin. Pharmacol., 9, 13\u201317.","journal-title":"Meth. Find. Exptl. Clin. Pharmacol."},{"key":"BF03189971_CR4","first-page":"510","volume":"22","author":"M.LL. Rutilant","year":"1977","unstructured":"Rutilant M.LL., Borrell M., Felez J., Diaz J.M., Vicente J.M. Garcia Rafanell J. (1977): Effect of triflusal (UR-15O1), a potential antithrombotic agent, on blood coagulation and platelet aggregation in man. Curr. Ther. Res., 22, 510\u2013521.","journal-title":"Curr. Ther. Res."},{"key":"BF03189971_CR5","first-page":"357","volume":"7","author":"M.J. Dominguez","year":"1985","unstructured":"Dominguez M.J., Vacas H., Saez Y., et al. (1985): Effects of triflusal in patients with prosthetic heart valves. Clin. Therap., 7, 357\u2013360.","journal-title":"Clin. Therap."},{"key":"BF03189971_CR6","first-page":"32","volume":"9","author":"E. Esmatjes","year":"1987","unstructured":"Esmatjes E. (1987): Microangiopatfa diabetica. Factores de riesgo. Biol. Clin. Hematol., 9, 32\u201333.","journal-title":"Biol. Clin. Hematol."},{"key":"BF03189971_CR7","first-page":"119","volume":"25","author":"R. Areas","year":"1981","unstructured":"Areas R., Herreros J., Rocha E., Honorato J., Azanza J. (1981): Estudio de la eficacia elfnicobiol\u00f3gica del triflusal en el postoperatorio de pacientes afectos de slndrome isqu\u00e9mico cr\u00f3nico de las extremidades. Rev. Med. Univ. Navarra, 25, 119\u2013123.","journal-title":"Rev. Med. Univ. Navarra"},{"key":"BF03189971_CR8","first-page":"791","volume":"25","author":"R. Marti","year":"1979","unstructured":"Marti R., Rocha E., Narvaiza M.J., Honorato J. (1979): Prevention of postoperative deep vein thrombosis (D.V.T.) by triflusal. Study of platelet aggregation, coagulation and DVT detection with 125-I-fibrinogen. Curr. Ther. Res., 25, 791\u2013803.","journal-title":"Curr. Ther. Res."},{"key":"BF03189971_CR9","first-page":"89","volume":"8","author":"F. Gala","year":"1986","unstructured":"Gala F., Garcia P., Gomez J.J., Garcia-Morato P. (1986): Profilaxis de la trombosis venosa profunda en traumatizados. Biol. Clin. Hematol., 8, 89.","journal-title":"Biol. Clin. Hematol."},{"key":"BF03189971_CR10","first-page":"43","volume":"9","author":"C. Castellamau","year":"1987","unstructured":"Castellamau C. (1987): Nuevas aportaciones del triflusal como antiagregante antiplaquetario. Biol. Clin. Hematol., 9,43.","journal-title":"Biol. Clin. Hematol."},{"key":"BF03189971_CR11","first-page":"125","volume":"2","author":"E. Garcia","year":"1985","unstructured":"Garcia E., Marquez M., Orozco M., et al. (1985): Valoraci\u00f3n cl\u00ednica y anal\u00edtica del triflusal. Un antiagregante plaquetario en pacientes geri\u00e1tricos con alto riesgo de enfennedad troemb\u00f3lica. An. Geri\u00e1L Geront, 2, 125\u2013129.","journal-title":"An. Geri\u00e1L Geront"},{"key":"BF03189971_CR12","first-page":"206","volume":"12","author":"V. Rimbau","year":"1982","unstructured":"Rimbau V., Fom J. (1982): Triflusal disposition \u201cin vivo\u201d. Haemostasis, 12, 206.","journal-title":"Haemostasis"},{"key":"BF03189971_CR13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF03189970","volume":"16","author":"J. Ramis","year":"1991","unstructured":"Ramis J., Mis R., Fom J. (1991): Pharmacokinetics of triflusal and its main metabolite in rats and dogs. Eur. J. Drug Metab. Pharmacokinet, 16, 261\u2013268","journal-title":"Eur. J. Drug Metab. Pharmacokinet"},{"key":"BF03189971_CR14","first-page":"198","volume":"13","author":"V. Rimbau","year":"1982","unstructured":"Rimbau V., Torralba A., Fom J. (1982): Estudios de distribuc\u00edon en rata y rat\u00f3n del triflusal-14C y de sus metabolites. J. Pharmac. (Paris), 13, 198\u2013199.","journal-title":"J. Pharmac. (Paris)"},{"key":"BF03189971_CR15","first-page":"11","volume":"7","author":"V. Rimbau","year":"1981","unstructured":"Rimbau V., Lopez R., Fernandez A., Fom J. (1981): Estudio farmacocin\u00e9tico del triflusal (UR-1501). Arch. Farm. Toxicol., 7, 11\u201316.","journal-title":"Arch. Farm. Toxicol."},{"key":"BF03189971_CR16","volume-title":"PCNONLIN. User\u2019s Guide","author":"C.M. Metzler","year":"1985","unstructured":"Metzler C.M., Weiner D.L. (1985): PCNONLIN. User\u2019s Guide. Lexington, Statistical Consultants Inc."},{"key":"BF03189971_CR17","volume-title":"Fundamentals of Clinical Pharmacokinetics","author":"J.G. Wagner","year":"1975","unstructured":"Wagner J.G. (1975): Fundamentals of Clinical Pharmacokinetics. Hamilton, Illinois, Drug Intelligence Publications."},{"key":"BF03189971_CR18","doi-asserted-by":"crossref","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M. Gibaldi","year":"1982","unstructured":"Gibaldi M., Perrier D. (1982): Pharmacokinetics. New York, Dekker."},{"key":"BF03189971_CR19","volume-title":"SPSS7PC+ for the IBM PC\/XT\/AT","author":"M.J. Norusis","year":"1986","unstructured":"Norusis M.J. (1986): SPSS7PC+ for the IBM PC\/XT\/AT. Chicago, SPSS Inc."},{"key":"BF03189971_CR20","first-page":"343","volume":"237","author":"J. Garcia Rafanell","year":"1979","unstructured":"Garcia Rafanell J., Planas J.M., Puig Parellada P. (1979): Biochemical profile of a new antithrombotic agent: triflusal (UR-1501). Arch. Int Pharmacodyn. Ther., 237, 343\u2013350.","journal-title":"Arch. Int Pharmacodyn. Ther."},{"key":"BF03189971_CR21","unstructured":"Garcia Rafanell J., Gomez L., Fom J. (1984): Peifil bioqufmico de un nuevo antiagregante plaquetario (triflusal) y su incidencia en el binomio hiperactividad plaquetaria-enfermedad tromb\u00f3tica. Esplugues J. Ed. Proceedings of the International Workshop on the Pharmacology of the Vascular Wall. Universidad de Valencia, pp. 446."},{"key":"BF03189971_CR22","first-page":"155","volume":"284","author":"J. Garcia Rafanell","year":"1986","unstructured":"Garcia Rafanell J., Ramis J., Gomez L., Fom J. (1986): Effect of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets. Arch. Int Pharmacodyn. Ther., 284, 155\u2013165.","journal-title":"Arch. Int Pharmacodyn. Ther."},{"key":"BF03189971_CR23","first-page":"105","volume":"9","author":"J. Pavia","year":"1987","unstructured":"Pavia J., De la Cruz J.P., Gonzalez F., Sanchez de la Cuesta F. (1987): Efecto antiagregante plaquetario del triflusal en sangre total. Rev. Esp. Tromb. Hemos., 9, 105.","journal-title":"Rev. Esp. Tromb. Hemos."},{"key":"BF03189971_CR24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0020-7101(83)90002-8","volume":"14","author":"P.K. Ng","year":"1983","unstructured":"Ng P.K., Collins-Nakai R.X. (1983): Prediction of multiple-dose blood level curves of drugs with rapid changes in doses and\/or dosing intervals. Int J. Biomed. Comput., 14, 275\u2013286.","journal-title":"Int J. Biomed. Comput."},{"key":"BF03189971_CR25","first-page":"11","volume":"4","author":"M. Albors","year":"1987","unstructured":"Albors M., Castellamau C., Villa L., Sola J., Rutilant M.LL. (1987): Inhibition of thromboxane production and platelet function by triflusal in healthy volunteers. Rev. Farmacol. Clin. Exp., 4, 11\u201316.","journal-title":"Rev. Farmacol. Clin. Exp."},{"key":"BF03189971_CR26","first-page":"456","volume":"7","author":"L.J. Aarons","year":"1977","unstructured":"Aarons L.J., Bochner F., Rowland M. (1977): A chronic dose-ranging kinetic study of salicylate in man. Proc. BPS, 7, 456\u2013457.","journal-title":"Proc. BPS"},{"key":"BF03189971_CR27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.1780140412","volume":"14","author":"H.E. Paulus","year":"1971","unstructured":"Paulus H.E., Siegel M., Mongan E., Okan R., Calaho J..(1971): Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis. Arth. Rheum., 14, 527\u2013532.","journal-title":"Arth. Rheum."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189971.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03189971\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T19:23:45Z","timestamp":1635967425000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03189971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1991,10]]}},"alternative-id":["BF03189971"],"URL":"https:\/\/doi.org\/10.1007\/bf03189971","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,10]]}}}